Skip to main content
Top
Published in: Immunity & Ageing 1/2021

Open Access 01-12-2021 | Correction

Correction to: A novel murine model of multi-day moderate ethanol exposure reveals increased intestinal dysfunction and liver inflammation with age

Authors: Rachel H. McMahan, Kevin M. Najarro, Juliet E. Mullen, Madison T. Paul, David J. Orlicky, Holly J. Hulsebus, Elizabeth J. Kovacs

Published in: Immunity & Ageing | Issue 1/2021

Login to get access

Excerpt

Correction to: Immun Ageing 18, 37 (2021)
Metadata
Title
Correction to: A novel murine model of multi-day moderate ethanol exposure reveals increased intestinal dysfunction and liver inflammation with age
Authors
Rachel H. McMahan
Kevin M. Najarro
Juliet E. Mullen
Madison T. Paul
David J. Orlicky
Holly J. Hulsebus
Elizabeth J. Kovacs
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Immunity & Ageing / Issue 1/2021
Electronic ISSN: 1742-4933
DOI
https://doi.org/10.1186/s12979-021-00250-z

Other articles of this Issue 1/2021

Immunity & Ageing 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine